Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3428

1.

Long-term outcomes following isolated arthroscopic Bankart repair: a 9- to 12-year follow-up.

Ono Y, Dávalos Herrera DA, Woodmass JM, Lemmex DB, Carroll MJ, Yamashita S, Thornton GM, Lo IK.

JSES Open Access. 2019 Aug 9;3(3):189-193. doi: 10.1016/j.jses.2019.05.002. eCollection 2019 Oct.

PMID:
31720496
2.

Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase?

Ikeda T, Ikenoshita S, Sakamoto F, Shiraishi S, Nakahara K, Masuda T, Yamashita S.

Neurodegener Dis. 2019 Nov 12;19(2):88-95. doi: 10.1159/000504006. [Epub ahead of print]

PMID:
31715596
3.

Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.

Ohta S, Morine Y, Imura S, Ikemoto T, Arakawa Y, Iwahashi S, Saito YU, Yamada S, Wada Y, Yamashita S, Bando Y, Shimada M.

Anticancer Res. 2019 Nov;39(11):6025-6033. doi: 10.21873/anticanres.13808.

PMID:
31704828
4.

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.

Yamashita S, Arai H, Yokote K, Araki E, Matsushita M, Nojima T, Suganami H, Ishibashi S.

Int J Mol Sci. 2019 Nov 6;20(22). pii: E5537. doi: 10.3390/ijms20225537.

5.

Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy.

Suzuki K, Akita S, Yoshimoto H, Ohtsuru A, Hirano A, Yamashita S.

Int J Mol Sci. 2019 Nov 5;20(21). pii: E5505. doi: 10.3390/ijms20215505.

6.

Roles of the indole ring of Trp396 covalently bound with the imidazole ring of His398 coordinated to type I copper in bilirubin oxidase.

Kataoka K, Ito T, Okuda Y, Sakai Y, Yamashita S, Sakurai T.

Biochem Biophys Res Commun. 2019 Oct 31. pii: S0006-291X(19)32067-4. doi: 10.1016/j.bbrc.2019.10.159. [Epub ahead of print]

PMID:
31679691
7.

Congenital vascular ring.

Yoshimura N, Fukahara K, Yamashita A, Doi T, Yamashita S, Homma T, Yokoyama S, Aoki M, Higashida A, Shimada Y, Toritsuka D, Nagao K, Ikeno Y.

Surg Today. 2019 Nov 1. doi: 10.1007/s00595-019-01907-5. [Epub ahead of print] Review.

PMID:
31676999
8.

Accuracy of Clasps Fabricated with Three Different CAD/CAM Technologies: Casting, Milling, and Selective Laser Sintering.

Tasaka A, Kato Y, Odaka K, Matsunaga S, Goto TK, Abe S, Yamashita S.

Int J Prosthodont. 2019 Nov/Dec;32(6):526-529. doi: 10.11607/ijp.6363.

PMID:
31664269
9.

Utility of a ripple map for the interpretation of atrial propagation during atrial tachycardia.

Yagishita A, Takahashi Y, Kawabata M, Kaneko M, Sekigawa M, Yamamoto T, Akiyoshi K, Shirai Y, Maeda S, Yamashita S, Suzuki M, Sasaki T, Goya M, Hirao K.

J Interv Card Electrophysiol. 2019 Oct 25. doi: 10.1007/s10840-019-00638-4. [Epub ahead of print]

PMID:
31654337
10.

Factors associated with longitudinal changes in serum concentrations of Mac-2 binding protein: A prospective 3-year observational study.

Sugiura T, Dohi Y, Takase H, Yamashita S, Tsuzuki Y, Ogawa S, Tanaka Y, Ohte N.

Nutr Metab Cardiovasc Dis. 2019 Aug 24. pii: S0939-4753(19)30313-8. doi: 10.1016/j.numecd.2019.08.008. [Epub ahead of print]

PMID:
31653515
11.

Thrombosis incidence after recombinant active factor VII administration in paediatric cardiac surgery.

Tachi K, Takahashi S, Ishigaki M, Nakayama S, Yamashita S, Hiramatsu Y, Tanaka M.

Indian J Anaesth. 2019 Oct;63(10):856-859. doi: 10.4103/ija.IJA_181_19. Epub 2019 Oct 10. No abstract available.

12.

Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.

Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M, Yamada K, Uetani H, Yamashita Y, Wang Y.

J Neurol Sci. 2019 Nov 15;406:116443. doi: 10.1016/j.jns.2019.116443. Epub 2019 Aug 31.

PMID:
31634718
13.

Chemical Properties and Nutritional Value of Plant-Origin Glucosylceramide.

Yamashita S, Kikuchi N, Kinoshita M, Miyazawa T.

J Nutr Sci Vitaminol (Tokyo). 2019;65(Supplement):S153-S157. doi: 10.3177/jnsv.65.S153.

14.

Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells.

Mizuguchi A, Yamashita S, Yokogami K, Morishita K, Takeshima H.

J Neurooncol. 2019 Oct 15. doi: 10.1007/s11060-019-03310-z. [Epub ahead of print]

PMID:
31617054
15.

Evaluation of the accuracy of urine analyzers in dogs and cats.

Mie K, Hayashi A, Nishida H, Okamoto M, Yasuda K, Nakata M, Fukatsu K, Matsunami N, Yamashita S, Ohashi F, Akiyoshi H.

J Vet Med Sci. 2019 Oct 11. doi: 10.1292/jvms.18-0468. [Epub ahead of print]

16.

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases.

Allard MA, Nishioka Y, Beghdadi N, Imai K, Gelli M, Yamashita S, Kitano Y, Kokudo T, Yamashita YI, Sa Cunha A, Vibert E, Elias D, Cherqui D, Goere D, Adam R, Baba H, Hasegawa K.

BJS Open. 2019 May 14;3(5):678-686. doi: 10.1002/bjs5.50174. eCollection 2019 Oct.

17.

Statin Intolerance Clinical Guide 2018.

Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A; Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics.

J Atheroscler Thromb. 2019 Oct 4. doi: 10.5551/jat.50948. [Epub ahead of print] No abstract available.

18.

Drosophila melanogaster as a model for understanding polyADP-ribosylation.

Miwa M, Hanai S, Yamashita S, Tanaka M, Uchida K.

Front Biosci (Landmark Ed). 2020 Jan 1;25:118-133.

PMID:
31585880
19.

Thyroid Cancer after Exposure to Radioiodine in Childhood and Adolescence: 131I-Related Risk and the Role of Selected Host and Environmental Factors.

Zupunski L, Ostroumova E, Drozdovitch V, Veyalkin I, Ivanov V, Yamashita S, Cardis E, Kesminiene A.

Cancers (Basel). 2019 Oct 2;11(10). pii: E1481. doi: 10.3390/cancers11101481.

20.

Side-chain oxysterols suppress the transcription of CTP: Phosphoethanolamine cytidylyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase by inhibiting the interaction of p300 and NF-Y, and H3K27 acetylation.

Ando H, Horibata Y, Aoyama C, Shimizu H, Shinohara Y, Yamashita S, Sugimoto H.

J Steroid Biochem Mol Biol. 2019 Sep 30;195:105482. doi: 10.1016/j.jsbmb.2019.105482. [Epub ahead of print]

PMID:
31580889
21.

Factors Associated with Unsuccessful Recanalization in Mechanical Thrombectomy for Acute Ischemic Stroke.

Goda T, Oyama N, Kitano T, Iwamoto T, Yamashita S, Takai H, Matsubara S, Uno M, Yagita Y.

Cerebrovasc Dis Extra. 2019 Sep 27;9(3):107-113. doi: 10.1159/000503001. [Epub ahead of print]

22.

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.

Kaya D, Kaji K, Tsuji Y, Yamashita S, Kitagawa K, Ozutsumi T, Fujinaga Y, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H.

Cells. 2019 Sep 26;8(10). pii: E1153. doi: 10.3390/cells8101153.

23.

Proliferative Fasciitis/Myositis Involving the Facial Muscles Including the Masseter Muscle: A Rare Cause of Trismus.

Nishi TM, Yamashita S, Hirakawa YN, Katsuki NE, Tago M, Yamashita SI.

Am J Case Rep. 2019 Sep 25;20:1411-1417. doi: 10.12659/AJCR.917193.

24.

FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.

Darwis NDM, Nachankar A, Sasaki Y, Matsui T, Noda SE, Murata K, Tamaki T, Ando K, Okonogi N, Shiba S, Irie D, Kaminuma T, Kumazawa T, Anakura M, Yamashita S, Hirakawa T, Kakoti S, Hirota Y, Tokino T, Iwase A, Ohno T, Shibata A, Oike T, Nakano T.

Int J Mol Sci. 2019 Sep 14;20(18). pii: E4563. doi: 10.3390/ijms20184563.

25.

Astonishing improvement of destructive mandibular osteomyelitis by NSAIDs: A rare lesion site in a patient with SAPHO syndrome.

Tago M, Katsuki NE, Motomura S, Tokushima Y, Yamashita SI.

Clin Case Rep. 2019 Jul 27;7(9):1800-1801. doi: 10.1002/ccr3.2328. eCollection 2019 Sep.

26.

FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.

Iwabu J, Yamashita S, Takeshima H, Kishino T, Takahashi T, Oda I, Koyanagi K, Igaki H, Tachimori Y, Daiko H, Nakazato H, Nishiyama K, Lee YC, Hanazaki K, Ushijima T.

Sci Rep. 2019 Sep 16;9(1):13347. doi: 10.1038/s41598-019-50005-6.

27.

Erratum to 'Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice' [Eur. J. Pharmacol. 859 (2019) 172521].

Yamashita S, Kawakami Y, Sato H, Sugitani S, Goto M, Kato N.

Eur J Pharmacol. 2019 Nov 5;862:172633. doi: 10.1016/j.ejphar.2019.172633. Epub 2019 Sep 10. No abstract available.

PMID:
31519353
28.

Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report.

Takamiya M, Takahashi Y, Morimoto M, Morimoto N, Yamashita S, Abe K.

eNeurologicalSci. 2019 Aug 22;16:100204. doi: 10.1016/j.ensci.2019.100204. eCollection 2019 Sep.

29.

Radical scavenging and chemical repair of rutin observed by pulse radiolysis: as a basis for radiation protection.

Yu H, Yamashita S.

Free Radic Res. 2019 Oct;53(9-10):1005-1013. doi: 10.1080/10715762.2019.1667991. Epub 2019 Sep 26.

PMID:
31514547
30.

Accessory axillary breasts versus axillary tumours: diagnostic challenge.

Tago M, Katsuki NE, Yamashita SI.

BMJ Case Rep. 2019 Sep 11;12(9). pii: e231715. doi: 10.1136/bcr-2019-231715. No abstract available.

PMID:
31511274
31.

Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals.

Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T, Ikewaki K, Inagaki K, Shoji T, Bujo H, Miida T, Yoshida M, Kuzuya M, Yamashita S.

J Atheroscler Thromb. 2019 Sep 5. doi: 10.5551/jat.50187. [Epub ahead of print]

32.

Radiation-Induced Thyroid Cancers: Overview of Molecular Signatures.

Suzuki K, Saenko V, Yamashita S, Mitsutake N.

Cancers (Basel). 2019 Sep 2;11(9). pii: E1290. doi: 10.3390/cancers11091290. Review.

33.

Transposition of pulmonary veins for mobilization of residual right middle and lower lobes after carinal right upper lobectomy: a unique pulmonary hilar mobilization technique for safe tension-free airway anastomosis.

Shiraishi T, Yamamoto L, Moroga T, Imamura N, Miyahara S, Waseda R, Sato T, Yamashita SI, Iwasaki A.

Gen Thorac Cardiovasc Surg. 2019 Aug 30. doi: 10.1007/s11748-019-01192-6. [Epub ahead of print]

PMID:
31471858
34.

Glaucoma-Associated Mutations in the Optineurin Gene Have Limited Impact on Parkin-Dependent Mitophagy.

Chernyshova K, Inoue K, Yamashita SI, Fukuchi T, Kanki T.

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3625-3635. doi: 10.1167/iovs.19-27184.

PMID:
31469402
35.

Complete genome sequence of Nitratireductor sp. strain OM-1: A lipid-producing bacterium with potential use in wastewater treatment.

Okamura Y, Treu L, Campanaro S, Yamashita S, Nakai S, Takahashi H, Watanabe K, Angelidaki I, Aki T, Matsumura Y, Nakashimada Y.

Biotechnol Rep (Amst). 2019 Aug 9;24:e00366. doi: 10.1016/j.btre.2019.e00366. eCollection 2019 Dec.

36.

Comparative analysis demonstrates cell type-specific conservation of SOX9 targets between mouse and chicken.

Yamashita S, Kataoka K, Yamamoto H, Kato T, Hara S, Yamaguchi K, Renard-Guillet C, Katou Y, Shirahige K, Ochi H, Ogino H, Uchida T, Inui M, Takada S, Shigenobu S, Asahara H.

Sci Rep. 2019 Aug 29;9(1):12560. doi: 10.1038/s41598-019-48979-4.

37.

Accuracy of removable partial denture framework fabricated by casting with a 3D printed pattern and selective laser sintering.

Tasaka A, Shimizu T, Kato Y, Okano H, Ida Y, Higuchi S, Yamashita S.

J Prosthodont Res. 2019 Aug 26. pii: S1883-1958(19)30294-4. doi: 10.1016/j.jpor.2019.07.009. [Epub ahead of print]

PMID:
31466919
38.

Impact of fracture characteristics and disease-specific complications on health-related quality of life in osteogenesis imperfecta.

Matsushita M, Mishima K, Yamashita S, Haga N, Fujiwara S, Ozono K, Kubota T, Kitaoka T, Ishiguro N, Kitoh H.

J Bone Miner Metab. 2019 Aug 13. doi: 10.1007/s00774-019-01033-9. [Epub ahead of print]

PMID:
31463628
39.

Comparison of atrial arrhythmia recurrence after persistent atrial fibrillation ablation between patients with or without tachycardia-induced cardiomyopathy.

Yamashita S, Tokuda M, Matsuo S, Mahida S, Hachisuka EO, Sato H, Ikewaki H, Oseto H, Yokoyama M, Isogai R, Tokutake K, Yokoyama K, Narui R, Kato M, Tanigawa S, Sugimoto K, Yoshimura M, Yamane T.

J Cardiovasc Electrophysiol. 2019 Nov;30(11):2310-2318. doi: 10.1111/jce.14144. Epub 2019 Sep 22.

PMID:
31452290
40.

Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation.

Yamashita S, Kimura E, Zhang Z, Tawara N, Hara K, Yoshimura A, Takashima H, Ando Y.

Muscle Nerve. 2019 Aug 26. doi: 10.1002/mus.26683. [Epub ahead of print]

PMID:
31449671
41.

Malnutrition diagnosed by controlling nutrition status is a negative predictor of life prognosis in aortic arch aneurysm patients treated with thoracic endovascular aneurysm repair.

Inoue K, Matsumoto T, Yamashita S, Yoshiga R, Yoshiya K, Matsubara Y, Matsuda D, Morisaki K, Furuyama T, Mori M.

Vascular. 2019 Aug 25:1708538119869458. doi: 10.1177/1708538119869458. [Epub ahead of print] No abstract available.

PMID:
31446849
42.

Ureteral wall volume at ureteral stone site is a critical predictor for shock wave lithotripsy outcomes: comparison with ureteral wall thickness and area.

Yamashita S, Kohjimoto Y, Iguchi T, Nishizawa S, Kikkawa K, Hara I.

Urolithiasis. 2019 Aug 23. doi: 10.1007/s00240-019-01154-w. [Epub ahead of print]

PMID:
31444520
43.

Use of in-Hospital Geomagnetic Fingerprinting Localization.

Yamashita K, Oyama S, Otani T, Yamashita S, Furukawa T, Kobayashi D, Sato K, Sugano A, Funada C, Mori K, Shiratori Y.

Stud Health Technol Inform. 2019 Aug 21;264:2007-2008. doi: 10.3233/SHTI190758.

PMID:
31438452
44.

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.

Ouchi Y, Sasaki J, Arai H, Yokote K, Harada K, Katayama Y, Urabe T, Uchida Y, Hayashi M, Yokota N, Nishida H, Otonari T, Arai T, Sakuma I, Sakabe K, Yamamoto M, Kobayashi T, Oikawa S, Yamashita S, Rakugi H, Imai T, Tanaka S, Ohashi Y, Kuwabara M, Ito H.

Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22.

PMID:
31434507
45.

Localized lymphedema after treatment for soft tissue sarcoma in the lower limbs: Comparison of improvement according to duration before lymphaticovenular anastomosis.

Yoshida S, Koshima I, Imai H, Uchiki T, Sasaki A, Fujioka Y, Nagamatsu S, Yokota K, Harima M, Yamashita S.

Clin Case Rep. 2019 Jun 28;7(8):1534-1538. doi: 10.1002/ccr3.2278. eCollection 2019 Aug.

46.

Intravascular Large B-Cell Lymphoma Presenting with Hypoxemia without any Abnormalities on Standard Imaging Studies.

Tokushima M, Katsuki NE, Tago M, Yamashita SI.

Am J Case Rep. 2019 Aug 14;20:1199-1204. doi: 10.12659/AJCR.916877.

47.

Surface Engineering of Fluoropolymer Films via the Attachment of Crown Ether Derivatives Based on the Combination of Radiation-Induced Graft Polymerization and the Kabachnik-Fields Reaction.

Omichi M, Yamashita S, Okura Y, Ikutomo R, Ueki Y, Seko N, Kakuchi R.

Polymers (Basel). 2019 Aug 12;11(8). pii: E1337. doi: 10.3390/polym11081337.

48.

CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.

Yamashita S, Matsuo Y, Tawara N, Hara K, Yamamoto M, Nishikami T, Kawakami K, Zhang X, Zhang Z, Doki T, Ando Y.

Sci Rep. 2019 Aug 12;9(1):11606. doi: 10.1038/s41598-019-48115-2.

49.

Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?

Fruchart JC, Santos RD, Yamashita S, Libby P; International Atherosclerosis Society/R3i Foundation Consensus Panel.

Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2723-2725. doi: 10.1016/j.dsx.2019.05.034. Epub 2019 May 30. Review. No abstract available.

PMID:
31405699
50.

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.

Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group.

Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5.

PMID:
31397289

Supplemental Content

Loading ...
Support Center